Jeff Yass’s Kazia Therapeutics KZIA Stock Holding History

Jeff Yass’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$713K	Buy	+50,616	New	+$617K	﹤0.01%	9058
2024 Q3	–	Sell	-830	Closed	-$16.6K	–	12549
2024 Q2	$9.46K	Buy	+830	New	+$12.3K	﹤0.01%	11782
2022 Q2	–	Sell	-501	Closed	-$192K	–	13470
2022 Q1	$192K	Sell	501 -514	-51%	-$184K	﹤0.01%	11284
2021 Q4	$429K	Buy	1,015 +525	+107%	+$262K	﹤0.01%	9577
2021 Q3	$281K	Buy	490 +204	+71%	+$100K	﹤0.01%	10744
2021 Q2	$141K	Sell	286 -200	-41%	-$105K	﹤0.01%	11888
2021 Q1	$301K	Buy	+486	New	+$254K	﹤0.01%	10598
2019 Q1	–	Sell	-220	Closed	-$25K	–	9394
2018 Q4	$25K	Sell	220 -2	-0.9%	-$272	﹤0.01%	8642
2018 Q3	$37K	Buy	+222	New	+$37.7K	﹤0.01%	8909

Other funds holding KZIA

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jeff Yass's KZIA Position: Q2 2026 in Review

Jeff Yass opened a new position in Kazia Therapeutics (KZIA) in Q2 2026: 50,616 shares worth $713K. The stake represents ﹤0.01% of the portfolio and ranks #9058 among its holdings. This is a return to the name: Jeff Yass previously reported a position in KZIA as recently as Q2 2024.

Jeff Yass first reported a position in KZIA in Q3 2018 and has held it in 9 quarters since. 36 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

Jeff Yass held 50,616 shares of Kazia Therapeutics worth $713K as of Q2 2026.
Kazia Therapeutics was a new Jeff Yass position in Q2 2026.
Kazia Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9058 holding.
Jeff Yass first reported a position in Kazia Therapeutics in Q3 2018 and has held it in 9 quarters since.
36 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.